Total Funding
56
56
Total FundingPost-IPO Equity raised
Growth Score
-2 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
272456
Prostatype Genomics AB is a Med-tech company, that manufactures, markets and sells the prognostic gene test Prostatype.
- Anders Koch: CFO
- Steven Gaal: President, USA
About the Company
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene test Prostatype. By giving a comprehensive assessment of the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under-treatment of prostate cancer can be minimized, the quality of life for the patient
improved and money can be saved for the health care sector.
